Kezar Life Sciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50M

Kezar Life Sciences General Information

Description

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 4000 Shoreline Court
  • Suite 300
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4000 Shoreline Court
  • Suite 300
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kezar Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 11-May-2026 $50M Completed Generating Revenue
8. Merger/Acquisition 08-Oct-2024 Cancelled Generating Revenue
7. General Corporate Purpose 10-Nov-2021 Completed Generating Revenue
6. PIPE 12-Feb-2021 Completed Generating Revenue
5. PIPE 14-Feb-2020 Completed Generating Revenue
4. PIPE 31-Mar-2019 Completed Generating Revenue
3. IPO 21-Jun-2018 Completed Generating Revenue
2. Early Stage VC (Series B) 25-Jul-2017 $50M $73M Completed Generating Revenue
1. Early Stage VC (Series A) 05-Jun-2015 $23M $23M Completed Startup
To view Kezar Life Sciences’s complete valuation and funding history, request access »

Kezar Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Kezar Life Sciences’s complete cap table history, request access »

Kezar Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel sma
Drug Discovery
South San Francisco, CA
9 As of 2026

New Haven, CT
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kezar Life Sciences Competitors (67)

One of Kezar Life Sciences’s 67 competitors is Arvinas, a Formerly VC-backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arvinas Formerly VC-backed New Haven, CT
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Lycia Therapeutics Formerly VC-backed South San Francisco, CA
Praxis (Drug Discovery) Formerly VC-backed Boston, MA
PharmAbcine Corporate Backed or Acquired Daejeon, South Korea
You’re viewing 5 of 67 competitors. Get the full list »

Kezar Life Sciences Patents

Kezar Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026183140-A1 Dosing regimens for zetomipzomib Pending 25-Feb-2025
WO-2023164250-A1 Sec61 inhibitors and use thereof Inactive 28-Feb-2022
JP-2023539553-A Protein secretion inhibitor Pending 31-Aug-2020
AU-2021334388-A1 Protein secretion inhibitors Inactive 31-Aug-2020
CA-3190441-A1 Protein secretion inhibitors Pending 31-Aug-2020 C07D417/14
To view Kezar Life Sciences’s complete patent history, request access »

Kezar Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kezar Life Sciences ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

35.49 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Kezar Life Sciences’s complete esg history, request access »

Kezar Life Sciences FAQs

  • When was Kezar Life Sciences founded?

    Kezar Life Sciences was founded in 2015.

  • Where is Kezar Life Sciences headquartered?

    Kezar Life Sciences is headquartered in South San Francisco, CA.

  • What is the size of Kezar Life Sciences?

    Kezar Life Sciences has 9 total employees.

  • What industry is Kezar Life Sciences in?

    Kezar Life Sciences’s primary industry is Drug Discovery.

  • Is Kezar Life Sciences a private or public company?

    Kezar Life Sciences is a Private company.

  • What is the current valuation of Kezar Life Sciences?

    The current valuation of Kezar Life Sciences is .

  • What is Kezar Life Sciences’s current revenue?

    The current revenue for Kezar Life Sciences is .

  • How much funding has Kezar Life Sciences raised over time?

    Kezar Life Sciences has raised $220M.

  • Who are Kezar Life Sciences’s competitors?

    Arvinas, Sarepta Therapeutics, Lycia Therapeutics, Praxis (Drug Discovery), and PharmAbcine are some of the 67 competitors of Kezar Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process